Big Gain For Virpax Pharmaceuticals Inc.
Fri, Dec 15, 2023 at 07:25 PM
Virpax Pharmaceuticals Inc. (VRPX:NASDAQ) rocketted at $0.39, representing a gain of 51.2%. On Fri, Dec 15, 2023, VRPX:NASDAQ touched a New 2-Week Intraday High of $0.49. From Fri, Dec 01, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Dec 15, 2023 at $0.49 with a volume of 10M+.
About Virpax Pharmaceuticals Inc. (VRPX:NASDAQ)
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management.
Top 10 Gainers:
- Signature Bank (SBNY:NASDAQ), 149.88%
- Getaround Inc. (GETR:NYSE), 84.85%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Battalion Oil Corporation (BATL:NYSEMKT), 81.8%
- Baudax Bio, Inc. (BXRX:NASDAQ), 65.05%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 61.97%
- Virpax Pharmaceuticals Inc. (VRPX:NASDAQ), 51.16%
- Brilliant Acquisition Corporation (BRLI:NASDAQ), 50%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 45.34%
- Northann Corp. (NCL:NYSEMKT), 42.14%